MGMT and central nervous system cancer: Methylation of the promoter of O(6)-methylguanine-DNA methyltransferase (MGMT) is directly related to the silencing of the repair protein MGMT, which leads to a special sensitivity to alkylating therapy, the current mainstay of glioma treatment (42).